Is an intraoperative liver funktion assessment possible? Application of the C-methacetin-breath-test during major liver resections - a pilot study
HPB (Oxford). 2023 Sep 6:S1365-182X(23)01928-7. doi: 10.1016/j.hpb.2023.09.006.
Implementation of deep learning in liver pathology optimizes diagnostis of benign lesions and andenocarcinoma metastasis
Clin Transl Med. 2023 Jul;13(7):e1299. doi: 10.1002/ctm2.1299.
Statement and Recommendations on Interventional Ultrasound as a Thyroid Diagnostic and Treatment Procedure
Ultrasound Med Biol 2018; 44: 14-36, doi: 10.1016/j.ultrasmedbio.2017.08.1889
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals.
Liver Cancer. 2018 May;7(2):190-204. doi: 10.1159/000486812. Epub 2018 Mar 1. PMID: 29888208; PMCID: PMC5985411.
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Lancet Gastroenterol Hepatol. 2023 Oct;8(10):879-907. doi: 10.1016/S2468-1253(23)00197-8. Epub 2023 Jul 27.
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany.
J Viral Hepat. 2022 Jul;29(7):536-542.
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
Lancet Gastroenterol Hepatol. 2022 May;7(5):396-415. doi: 10.1016/S2468-1253(21)00472-6.
Neue Therapieoptionen beim HCC und bei biliären Karzinomen
Verdauungskrankheiten, Jahrgang 41, in press.
The REMAR (Rhein-Main-Registry) real-world study: Prospective evaluation of the 21-Gene Breast Recurrence Score® Assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer.
Breast Cancer Res and Treatment. Submitted for publication, October 2023.
Effects of intermittend fasting on quality of life tolerance of chgemotherapy in patients with gynecological cancers: study protocol of a randomized controlled multi-center trial.
Frontiers in Oncology 7/2023. doi: 10.3389/fonc.2023.1222573.
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (Pelvic and Paraaortic Lymphadenectomy in Patients with Stage I or II Endometrial Cancer with High Risk of Recurrence; AGO-OP.6)
Int J Gyn Cancer 2021 31(7):1075-1079.
Use of the oncotype DX Assay in early breast cancer in certified breast cancer centers in Rhine-Main Region, Germany.
Cancer Res 2018; 78 (Suppl.4): Abstract OT1-06-02
PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Pleura Peritoneum. 2018; 25;3(3).
Jörg Heil, Antje Nixdorf, Gabriele Bonatz, Agnieszka Nolte, Isabel T. Rubio, Florentia Peintinger, Keyur Mehta, Sibylle Loibl, Edoardo Botteri, Oreste Davide Gentilini.
Omission of SLNB in triple-negative and HER2-positive breast cancer patients with radiologic and pathologic complete response in the breast after NAST: a single-arm, prospective surgical trial (EUBREAST-01 trial, GBG 104)
Cancer Res (2023) 83 (5_Supplement): OT1-07-01
Das unerwartete synchrone Auftreten zweier Tumorentitäten als diagnostische und therapeutische Herausforderung.
Der Gynäkologe 2/2022
PANTHERA- Studie “Pelvic floor disorders in patients under ANtineoplastic THERApy“ - Evaluation der subjektiv wahrgenommenen Beckenbodenfunktion bei Patientinnen mit gynäkologischen Tumoren und Mammakarzinom unter systemischer Tumortherapie mittels eines validierten Fragebogens - Interimsanalyse 2022.
Posterpräsentation DGGG 2022
Paraneoplastic autoimmun multiorgan syndrome (PAMS) als seltene Differenzialdiagnose bei onkologischen Patienten mit kutaner und systemischer Manifestation.
Posterpräsentation DGGG 2020
Which Reimbursement System Fits Inpatient Palliative Care? A Qualitative Interview Study on Clinicians' and Financing Experts' Experiences and Views.
J Palliat Med. 2019 Nov;22(11):1378-1385. doi: 10.1089/jpm.2019.0028. Epub 2019 Jun 17
Understanding complexity - the palliative care situation as a complex adaptive system.
BMC Health Serv Res. 2019 Mar 12;19(1):157. doi: 10.1186/s12913-019-3961-0.
Sequential use of the Demoralization Scale in palliative care: feasibility, strain, and personal benefits of participation for patients at the end of life.
Support Care Cancer. 2021 Feb;29(2):965-973. doi: 10.1007/s00520-020-05555-1. Epub 2020 Jun 16. PMID: 32556715.
